JP2021534182A5 - - Google Patents
Info
- Publication number
- JP2021534182A5 JP2021534182A5 JP2021507889A JP2021507889A JP2021534182A5 JP 2021534182 A5 JP2021534182 A5 JP 2021534182A5 JP 2021507889 A JP2021507889 A JP 2021507889A JP 2021507889 A JP2021507889 A JP 2021507889A JP 2021534182 A5 JP2021534182 A5 JP 2021534182A5
- Authority
- JP
- Japan
- Prior art keywords
- self
- composition according
- derived
- antigen
- immunogenic composition
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862719219P | 2018-08-17 | 2018-08-17 | |
| US62/719,219 | 2018-08-17 | ||
| PCT/EP2019/072052 WO2020035609A2 (en) | 2018-08-17 | 2019-08-16 | Immunogenic compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534182A JP2021534182A (ja) | 2021-12-09 |
| JPWO2020035609A5 JPWO2020035609A5 (https=) | 2022-08-22 |
| JP2021534182A5 true JP2021534182A5 (https=) | 2022-08-22 |
Family
ID=67766133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507889A Pending JP2021534182A (ja) | 2018-08-17 | 2019-08-16 | 免疫原性組成物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12083174B2 (https=) |
| EP (1) | EP3836963A2 (https=) |
| JP (1) | JP2021534182A (https=) |
| CN (1) | CN113164584A (https=) |
| AU (1) | AU2019321186B2 (https=) |
| CA (1) | CA3109165A1 (https=) |
| WO (1) | WO2020035609A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3727444A1 (en) | 2017-12-18 | 2020-10-28 | Intervet International B.V. | Swine influenza a virus vaccine |
| WO2021183563A1 (en) | 2020-03-09 | 2021-09-16 | Arcturus Therapeutics, Inc. | Coronavirus vaccine compositions and methods |
| EP4125944A4 (en) * | 2020-04-03 | 2024-08-14 | Gritstone bio, Inc. | ANTIGENS AND VACCINES AGAINST INFECTIOUS DISEASES |
| IL298363A (en) * | 2020-05-20 | 2023-01-01 | Flagship Pioneering Innovations Vi Llc | Immunogenic compositions and uses thereof |
| JP2023530132A (ja) * | 2020-06-19 | 2023-07-13 | インターベット インターナショナル ベー． フェー． | ２つの異なるｒｎａレプリコン粒子を含むブタインフルエンザａウイルスワクチン |
| US12178921B2 (en) | 2020-08-14 | 2024-12-31 | Arcturus Therapeutics, Inc. | Method of lyophilizing lipid nanoparticles |
| JP2023546175A (ja) | 2020-10-14 | 2023-11-01 | ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド | 脂質ナノ粒子製造の方法及びそれに由来する組成物 |
| IL303315A (en) * | 2020-12-02 | 2023-07-01 | Seqirus Inc | Multicistronic RNA components and their uses |
| KR20240009952A (ko) * | 2021-05-19 | 2024-01-23 | 다이이찌 산쿄 가부시키가이샤 | 인플루엔자 바이러스 핵산 지질 입자 백신 |
| AU2022396547A1 (en) * | 2021-11-29 | 2024-06-06 | Replicate Bioscience, Inc. | Methods of generating self-replicating rna molecules |
| WO2023213378A1 (en) * | 2022-05-02 | 2023-11-09 | BioNTech SE | Replicon compositions and methods of using same for the treatment of diseases |
| US20240009296A1 (en) * | 2022-07-10 | 2024-01-11 | Pfizer Inc. | Self-amplifying rna encoding an influenza virus antigen |
| KR20250140103A (ko) * | 2023-02-09 | 2025-09-24 | 화이자 인코포레이티드 | 핵산 및 이의 용도 |
| WO2024254461A2 (en) * | 2023-06-07 | 2024-12-12 | Nutech Ventures | Methods and compositions for vaccine development and delivery |
| EP4727579A1 (en) * | 2023-06-19 | 2026-04-22 | Seqirus Inc. | Multivalent subtype influenza vaccine |
| CN117205309B (zh) * | 2023-11-07 | 2024-02-02 | 今发制药(南京)有限公司 | 一种流感免疫原组合物和制备方法及其用途 |
| WO2025210141A1 (en) * | 2024-04-05 | 2025-10-09 | Boehringer Ingelheim Vetmedica Gmbh | Delivery system useful for topical administration of rna |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| EP1751289B1 (en) | 2004-05-18 | 2009-01-14 | Alphavax, Inc. | Tc-83-derived alphavirus vectors, particles and methods |
| US20110300205A1 (en) * | 2009-07-06 | 2011-12-08 | Novartis Ag | Self replicating rna molecules and uses thereof |
| WO2011076807A2 (en) | 2009-12-23 | 2011-06-30 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
| RS63817B1 (sr) | 2010-07-06 | 2023-01-31 | Glaxosmithkline Biologicals Sa | Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk |
| HUE026646T2 (en) | 2010-07-06 | 2016-07-28 | Glaxosmithkline Biologicals Sa | Preferred liposomes containing lipids of PKA value for delivery of RNA |
| EP2590625B1 (en) | 2010-07-06 | 2017-09-20 | GlaxoSmithKline Biologicals SA | Cationic oil-in-water emulsions |
| PT3970742T (pt) | 2010-08-31 | 2022-06-27 | Glaxosmithkline Biologicals Sa | Lipossomas peguilados para entrega de arn codificador de imunogénio |
| ES2727583T3 (es) | 2010-08-31 | 2019-10-17 | Glaxosmithkline Biologicals Sa | Lípidos adecuados para la administración liposómica de ARN que codifica proteínas |
| RS63890B1 (sr) | 2010-08-31 | 2023-02-28 | Glaxosmithkline Biologicals Sa | Mali lipozomi za isporuku rnk koja kodira imunogen |
| CA2840965C (en) | 2011-07-06 | 2021-03-02 | Novartis Ag | Cationic oil-in-water emulsions |
| US20140141070A1 (en) | 2011-07-06 | 2014-05-22 | Andrew Geall | Liposomes having useful n:p ratio for delivery of rna molecules |
| SG10201605512WA (en) * | 2011-07-06 | 2016-09-29 | Novartis Ag | Oil-in-water emulsions that contain nucleic acids |
| US11058762B2 (en) | 2011-07-06 | 2021-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| EP3508220A1 (en) | 2011-08-31 | 2019-07-10 | GlaxoSmithKline Biologicals S.A. | Pegylated liposomes for delivery of immunogen-encoding rna |
| BR112014008694A2 (pt) * | 2011-10-11 | 2017-06-20 | Novartis Ag | moléculas de ácido nucleico policistrônico recombinante |
| EP2943221A1 (en) * | 2013-01-10 | 2015-11-18 | Novartis AG | Influenza virus immunogenic compositions and uses thereof |
| EP3608308B1 (en) | 2013-03-08 | 2021-07-21 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| EP4019506A1 (en) | 2013-12-19 | 2022-06-29 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| JP2019511255A (ja) * | 2016-01-11 | 2019-04-25 | バーンダリ，インク． | マイクロニードル組成物およびそれを使用する方法 |
| CN106822887A (zh) | 2017-01-26 | 2017-06-13 | 中国科学院微生物研究所 | 一种流感病毒四价亚单位疫苗及其应用 |
-
2019
- 2019-08-16 EP EP19758926.0A patent/EP3836963A2/en active Pending
- 2019-08-16 AU AU2019321186A patent/AU2019321186B2/en active Active
- 2019-08-16 CA CA3109165A patent/CA3109165A1/en active Pending
- 2019-08-16 JP JP2021507889A patent/JP2021534182A/ja active Pending
- 2019-08-16 CN CN201980068212.4A patent/CN113164584A/zh active Pending
- 2019-08-16 WO PCT/EP2019/072052 patent/WO2020035609A2/en not_active Ceased
- 2019-08-16 US US17/268,647 patent/US12083174B2/en active Active
-
2024
- 2024-08-06 US US18/795,336 patent/US20250064916A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534182A5 (https=) | ||
| Park et al. | mRNA vaccines for COVID-19: what, why and how | |
| Lu et al. | The potential neurological effect of the COVID‐19 vaccines: a review | |
| JP2015522580A5 (https=) | ||
| JP2014520807A5 (https=) | ||
| JPWO2020035609A5 (https=) | ||
| JP2014522842A5 (https=) | ||
| Mehraeen et al. | Vaccines for COVID-19: a systematic review of feasibility and effectiveness | |
| JP2014520806A5 (https=) | ||
| Simnani et al. | COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review | |
| EP3888676A1 (en) | Immunogenic combinations | |
| Lee et al. | Influenza viruses: innate immunity and mRNA vaccines | |
| HRP20230226T1 (hr) | Pegilirani liposomi za isporuku rna koja kodira imunogen | |
| JP2016539946A5 (https=) | ||
| JP2019526580A5 (https=) | ||
| JP2007211026A5 (https=) | ||
| JP2018514565A5 (https=) | ||
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2024537250A (ja) | インフルエンザワクチン | |
| JP2015524802A5 (https=) | ||
| JP2014519817A5 (https=) | ||
| Ftouh et al. | Contribution of nanotechnologies to vaccine development and drug delivery against respiratory viruses | |
| CN112294954B (zh) | 一种禽用佐剂组合物及其制备方法和应用 | |
| CN101843901A (zh) | 以纳米乳剂为佐剂的流感病毒疫苗及其制备方法 | |
| JPWO2022118226A5 (https=) |